These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 8383533

  • 1. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation.
    Corbett AH, Fernald AW, Osheroff N.
    Biochemistry; 1993 Mar 02; 32(8):2090-7. PubMed ID: 8383533
    [Abstract] [Full Text] [Related]

  • 2. Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis.
    Corbett AH, DeVore RF, Osheroff N.
    J Biol Chem; 1992 Oct 05; 267(28):20513-8. PubMed ID: 1328202
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II.
    Ackerman P, Glover CV, Osheroff N.
    J Biol Chem; 1988 Sep 05; 263(25):12653-60. PubMed ID: 2842338
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
    DeVore RF, Corbett AH, Osheroff N.
    Cancer Res; 1992 Apr 15; 52(8):2156-61. PubMed ID: 1313738
    [Abstract] [Full Text] [Related]

  • 5. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ, Corbett AH, Osheroff N.
    Biochemistry; 1993 Apr 13; 32(14):3638-43. PubMed ID: 8385484
    [Abstract] [Full Text] [Related]

  • 6. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.
    Robinson MJ, Osheroff N.
    Biochemistry; 1991 Feb 19; 30(7):1807-13. PubMed ID: 1847075
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro.
    Ackerman P, Glover CV, Osheroff N.
    Proc Natl Acad Sci U S A; 1985 May 19; 82(10):3164-8. PubMed ID: 2987912
    [Abstract] [Full Text] [Related]

  • 8. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.
    Kwon Y, Shin BS, Chung IK.
    J Biol Chem; 2000 Jun 16; 275(24):18503-10. PubMed ID: 10764786
    [Abstract] [Full Text] [Related]

  • 9. Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: phosphorylation of topoisomerase II and modification of its activity.
    Saijo M, Enomoto T, Hanaoka F, Ui M.
    Biochemistry; 1990 Jan 16; 29(2):583-90. PubMed ID: 2154252
    [Abstract] [Full Text] [Related]

  • 10. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
    Oestergaard VH, Giangiacomo L, Bjergbaek L, Knudsen BR, Andersen AH.
    J Biol Chem; 2004 Jul 02; 279(27):28093-9. PubMed ID: 15123700
    [Abstract] [Full Text] [Related]

  • 11. Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate.
    Zechiedrich EL, Christiansen K, Andersen AH, Westergaard O, Osheroff N.
    Biochemistry; 1989 Jul 25; 28(15):6229-36. PubMed ID: 2551367
    [Abstract] [Full Text] [Related]

  • 12. Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme.
    Corbett AH, Hong D, Osheroff N.
    J Biol Chem; 1993 Jul 05; 268(19):14394-8. PubMed ID: 8390992
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylation of the C-terminal domain of yeast topoisomerase II by casein kinase II affects DNA-protein interaction.
    Dang Q, Alghisi GC, Gasser SM.
    J Mol Biol; 1994 Oct 14; 243(1):10-24. PubMed ID: 7932731
    [Abstract] [Full Text] [Related]

  • 14. Eukaryotic topoisomerase II. Characterization of enzyme turnover.
    Osheroff N.
    J Biol Chem; 1986 Jul 25; 261(21):9944-50. PubMed ID: 3015913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
    Kingma PS, Corbett AH, Burcham PC, Marnett LJ, Osheroff N.
    J Biol Chem; 1995 Sep 15; 270(37):21441-4. PubMed ID: 7665552
    [Abstract] [Full Text] [Related]

  • 17. The catalytic activities of DNA topoisomerase II are most closely associated with the DNA cleavage/religation steps.
    Scala D, Escargueil AE, Couprie J, Larsen AK.
    Biochimie; 1999 Jul 15; 81(7):771-9. PubMed ID: 10492025
    [Abstract] [Full Text] [Related]

  • 18. Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediate.
    Gale KC, Osheroff N.
    Biochemistry; 1990 Oct 16; 29(41):9538-45. PubMed ID: 2176849
    [Abstract] [Full Text] [Related]

  • 19. Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction.
    Andersen AH, Christiansen K, Zechiedrich EL, Jensen PS, Osheroff N, Westergaard O.
    Biochemistry; 1989 Jul 25; 28(15):6237-44. PubMed ID: 2551368
    [Abstract] [Full Text] [Related]

  • 20. Z-DNA binding and inhibition by GTP of Drosophila topoisomerase II.
    Arndt-Jovin DJ, Udvardy A, Garner MM, Ritter S, Jovin TM.
    Biochemistry; 1993 May 11; 32(18):4862-72. PubMed ID: 8387819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.